data_2lq9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lq9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 CA-C-O 120.715 0.215 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.738 ' HD1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.738 ' N ' ' HD1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CD1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.489 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HA ' ' HG1' ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' N ' HD22 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 ' HG1' ' HA ' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 120.801 0.25 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CB ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 21' ' ' ARG . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 20' ' ' SER . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' HZ2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 2.3 m-80 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' HZ1' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.477 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 46' ' ' HIS . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 HD23 ' CB ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.56 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HZ2' HG11 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 120.72 0.216 . . . . 0.0 111.875 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.694 ' N ' HD21 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE2' ' O ' ' A' ' 2' ' ' PRO . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.648 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 48' ' ' MET . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.648 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.601 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HG1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.82 0.258 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 64' ' ' TYR . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.466 ' HG ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 20' ' ' SER . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 120.775 0.24 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.68 ' CD2' ' OG ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.472 ' CE1' ' C ' ' A' ' 63' ' ' SER . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' ' OG ' ' A' ' 20' ' ' SER . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.463 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.68 ' OG ' ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.474 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.418 ' HG1' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.564 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.469 ' HG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.471 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.742 0.226 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.42 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CG ' HD21 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD21 ' HG1' ' A' ' 50' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' CD2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 31' ' ' TYR . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.486 ' HG1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD21 ' CG ' ' A' ' 6' ' ' PHE . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.593 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.51 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 ' CG2' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.811 0.255 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.565 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 54' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.444 ' N ' HG22 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.624 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.597 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.784 0.243 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.427 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.47 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 35' ' ' LEU . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' N ' HD22 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.628 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.61 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.521 ' H ' ' HG1' ' A' ' 61' ' ' THR . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.832 0.263 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CE1' ' C ' ' A' ' 63' ' ' SER . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HZ1' ' HB2' ' A' ' 25' ' ' LYS . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 48' ' ' MET . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.424 ' HG1' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 ' CD2' ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.633 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD11 ' N ' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.491 ' HG1' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 ' CG2' ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.438 0 CA-C-O 120.861 0.275 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.41 HG21 ' H ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 54' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' N ' HG23 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.6 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.474 ' CG1' ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 6' ' ' PHE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.404 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.588 ' HG1' ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.542 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 CA-C-O 120.863 0.276 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.419 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 35' ' ' LEU . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.426 ' HG1' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.557 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' HZ2' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' A' ' 47' ' ' SER . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.47 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HA ' ' HG1' ' A' ' 11' ' ' THR . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.469 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 120.928 0.303 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.694 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CD1' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.476 HD11 HG23 ' A' ' 33' ' ' ILE . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.521 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.694 ' HG ' ' HD1' ' A' ' 4' ' ' HIS . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD21 ' CD1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.64 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 55' ' ' LEU . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.745 0.227 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.64 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.64 ' CB ' ' HD1' ' A' ' 4' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.4 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.887 0.286 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HB2' ' HG ' ' A' ' 47' ' ' SER . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' HD23 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HG21 ' A' ' 54' ' ' THR . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 4' ' ' HIS . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.562 ' CB ' ' O ' ' A' ' 47' ' ' SER . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.432 ' OG1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.642 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD23 ' CG2' ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 CA-C-O 120.821 0.259 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.678 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.774 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 39' ' ' LYS . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.595 ' CG1' ' O ' ' A' ' 54' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' ' OD1' ' A' ' 24' ' ' ASN . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HZ2' ' HB3' ' A' ' 7' ' ' SER . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' ' O ' ' A' ' 48' ' ' MET . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.774 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 55' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.51 ' OG1' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.45 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 120.648 0.187 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.664 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD11 ' HG1' ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.664 ' CB ' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.681 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 48' ' ' MET . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.681 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.599 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.41 ' HG1' HD11 ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 55' ' ' LEU . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.84 0.267 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CG ' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.46 ' C ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OG ' ' A' ' 47' ' ' SER . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 51' ' ' LEU . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.533 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 CA-C-O 120.862 0.276 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' SD ' ' A' ' 48' ' ' MET . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.597 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.468 ' SD ' ' NE2' ' A' ' 4' ' ' HIS . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.468 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.511 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.817 0.257 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' HZ1' ' A' ' 57' ' ' LYS . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.465 HD22 ' HG1' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HG ' HG21 ' A' ' 29' ' ' VAL . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.472 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' N ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 51' ' ' LEU . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HZ1' HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' H ' ' HZ3' ' A' ' 56' ' ' LYS . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo . . . . . 0 N--CA 1.491 1.36 0 CA-C-O 120.704 0.21 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.648 ' CD1' ' HG1' ' A' ' 54' ' ' THR . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HZ2' ' HB3' ' A' ' 38' ' ' LYS . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' CD1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' N ' HD23 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.529 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.648 ' HG1' ' CD1' ' A' ' 23' ' ' LEU . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.02 146.23 22.82 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.908 2.405 . . . . 0.0 112.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.738 ' HD1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.738 ' N ' ' HD1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CD1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.489 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HA ' ' HG1' ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.486 ' N ' HD22 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 ' HG1' ' HA ' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.94 156.3 9.0 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -134.5 151.73 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 5.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.618 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.48 144.37 15.92 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.839 2.36 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLU . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CB ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 21' ' ' ARG . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 20' ' ' SER . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' HZ2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 2.3 m-80 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' HZ1' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' OE2' ' O ' ' A' ' 1' ' ' MET . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.477 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 46' ' ' HIS . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 HD23 ' CB ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.56 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HZ2' HG11 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.42 -170.87 34.6 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 46.5 mt -105.26 150.9 24.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.59 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 19.2 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -63.42 140.06 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.838 2.359 . . . . 0.0 111.875 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' HD1' HD12 ' A' ' 67' ' ' LEU . 2.1 t60 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.694 ' N ' HD21 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 1' ' ' MET . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.648 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 48' ' ' MET . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.648 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.601 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HG1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.74 -168.05 26.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 ' HD1' ' A' ' 4' ' ' HIS . 4.4 tp -103.99 149.22 25.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.607 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 9.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.459 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 51.3 Cg_endo -73.33 148.4 43.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.803 2.335 . . . . 0.0 112.045 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.415 ' HD1' ' HG ' ' A' ' 67' ' ' LEU . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 64' ' ' TYR . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.466 ' HG ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 20' ' ' SER . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.38 -179.28 26.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 7.4 mp -112.84 138.33 49.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.641 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 1' ' ' MET . 53.1 Cg_endo -75.32 148.46 34.1 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.309 2.006 . . . . 0.0 111.979 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.68 ' CD2' ' OG ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.472 ' CE1' ' C ' ' A' ' 63' ' ' SER . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' ' OG ' ' A' ' 20' ' ' SER . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.68 ' OG ' ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.418 ' HG1' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.564 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.469 ' HG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.471 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.91 -175.85 17.15 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 6.1 mp -92.14 151.86 20.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.541 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.83 147.85 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.04 2.493 . . . . 0.0 112.324 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' GLU . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.42 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CG ' HD21 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD21 ' HG1' ' A' ' 50' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' CD2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 31' ' ' TYR . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.486 ' HG1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD21 ' CG ' ' A' ' 6' ' ' PHE . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.593 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.51 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 ' CG2' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . 163.22 -172.29 39.16 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 tt -121.27 129.78 53.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.423 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.54 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.69 151.64 24.61 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.864 2.376 . . . . 0.0 112.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.565 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 54' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.444 ' N ' HG22 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.624 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.597 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.32 160.05 8.31 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -90.28 152.29 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.602 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 1' ' ' MET . 47.9 Cg_exo -52.14 138.79 53.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.002 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.427 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 35' ' ' LEU . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' N ' HD22 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.628 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.61 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.521 ' H ' ' HG1' ' A' ' 61' ' ' THR . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.82 178.28 15.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 68' ' ' GLU . 11.4 mt -89.5 140.44 29.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.537 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.6 Cg_endo -69.39 157.3 61.63 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.614 2.21 . . . . 0.0 112.22 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CE1' ' C ' ' A' ' 63' ' ' SER . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HZ1' ' HB2' ' A' ' 25' ' ' LYS . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 48' ' ' MET . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.424 ' HG1' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' CD2' ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.633 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD11 ' N ' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.491 ' HG1' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 ' CG2' ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.81 -175.93 18.18 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' HD1' ' A' ' 4' ' ' HIS . 1.2 mt -98.37 151.98 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.63 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.584 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' H1 ' ' HD3' ' A' ' 2' ' ' PRO . 10.9 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HD3' ' H1 ' ' A' ' 1' ' ' MET . 55.4 Cg_endo -74.39 147.44 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.18 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.41 HG21 ' H ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 54' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' N ' HG23 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.6 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.474 ' CG1' ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 6' ' ' PHE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.404 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.588 ' HG1' ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.542 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.64 -160.44 22.24 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' N ' HD13 ' A' ' 67' ' ' LEU . 5.0 mp -118.23 144.62 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' H1 ' ' HD3' ' A' ' 2' ' ' PRO . 6.3 ttm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' HD3' ' H1 ' ' A' ' 1' ' ' MET . 54.4 Cg_endo -74.12 158.73 45.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.718 2.278 . . . . 0.0 112.247 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.419 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 35' ' ' LEU . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.426 ' HG1' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.557 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' HZ2' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' A' ' 47' ' ' SER . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.47 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HA ' ' HG1' ' A' ' 11' ' ' THR . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.469 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 157.95 -176.93 34.9 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' GLU . 1.9 mt -104.65 150.38 24.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 110.388 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' CG ' ' O ' ' A' ' 68' ' ' GLU . 4.9 tt0 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.432 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 6.4 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_endo -68.42 152.86 75.01 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.543 2.162 . . . . 0.0 112.179 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.694 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CD1' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.476 HD11 HG23 ' A' ' 33' ' ' ILE . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.521 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 1' ' ' MET . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.694 ' HG ' ' HD1' ' A' ' 4' ' ' HIS . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD21 ' CD1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.64 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 55' ' ' LEU . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.85 169.78 12.42 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.53 147.66 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.631 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.691 ' H3 ' ' CD ' ' A' ' 2' ' ' PRO . 1.2 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.691 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 25.1 Cg_exo -58.71 146.08 93.47 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.656 2.237 . . . . 0.0 111.828 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.64 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' A' ' 1' ' ' MET . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.64 ' CB ' ' HD1' ' A' ' 4' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.4 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.67 -138.21 7.23 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.03 150.46 38.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.702 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.43 136.52 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.455 ' HB2' ' HG ' ' A' ' 47' ' ' SER . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' HD23 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HG21 ' A' ' 54' ' ' THR . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 4' ' ' HIS . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.562 ' CB ' ' O ' ' A' ' 47' ' ' SER . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.432 ' OG1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.642 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD23 ' CG2' ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.04 -177.0 19.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -88.57 135.14 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.524 ' OE1' ' OXT' ' A' ' 68' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' CG ' ' A' ' 1' ' ' MET . 1.8 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo -73.7 137.16 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.321 . . . . 0.0 112.104 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.469 ' CE1' HD23 ' A' ' 67' ' ' LEU . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.678 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.774 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 39' ' ' LYS . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.595 ' CG1' ' O ' ' A' ' 54' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' ' OD1' ' A' ' 24' ' ' ASN . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HZ2' ' HB3' ' A' ' 7' ' ' SER . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' ' O ' ' A' ' 48' ' ' MET . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.774 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 55' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.51 ' OG1' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.45 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 160.93 -179.54 36.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 33.3 mt -101.13 136.69 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.567 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 2.5 tm-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' OE2' ' A' ' 45' ' ' GLU . 32.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.93 144.99 31.2 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.621 2.214 . . . . 0.0 112.028 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.664 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD11 ' HG1' ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' OE2' ' SD ' ' A' ' 1' ' ' MET . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.664 ' CB ' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.681 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 48' ' ' MET . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.681 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.599 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.41 ' HG1' HD11 ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 55' ' ' LEU . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 147.46 -170.74 28.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -129.2 141.54 51.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.257 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.441 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt0 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.594 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.648 ' H2 ' ' CD ' ' A' ' 2' ' ' PRO . 1.9 ttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.648 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 20.7 Cg_exo -61.49 159.39 32.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.879 2.386 . . . . 0.0 112.068 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.439 ' CE1' HD21 ' A' ' 67' ' ' LEU . 2.9 t60 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CG ' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.46 ' C ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OG ' ' A' ' 47' ' ' SER . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 51' ' ' LEU . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.533 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.35 174.82 20.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 4' ' ' HIS . 5.9 mt -89.13 140.45 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.559 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.1 139.22 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.241 . . . . 0.0 112.157 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' SD ' ' A' ' 48' ' ' MET . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.597 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.468 ' SD ' ' NE2' ' A' ' 4' ' ' HIS . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.511 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.24 149.17 4.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' O ' ' C ' ' A' ' 68' ' ' GLU . 1.3 tt -101.49 129.35 47.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.708 0.29 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' C ' ' O ' ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.07 147.8 88.55 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.824 2.35 . . . . 0.0 111.861 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' HZ1' ' A' ' 57' ' ' LYS . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD22 ' HG1' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HG ' HG21 ' A' ' 29' ' ' VAL . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.472 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' N ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 51' ' ' LEU . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HZ1' HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' H ' ' HZ3' ' A' ' 56' ' ' LYS . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.81 170.52 13.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -88.58 147.93 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.486 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.716 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.2 ttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 1' ' ' MET . 8.9 Cg_exo -67.5 136.41 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.623 2.215 . . . . 0.0 111.938 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.648 ' CD1' ' HG1' ' A' ' 54' ' ' THR . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HZ2' ' HB3' ' A' ' 38' ' ' LYS . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' CD1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' N ' HD23 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.529 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.648 ' HG1' ' CD1' ' A' ' 23' ' ' LEU . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.7 -143.58 10.96 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.64 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.91 150.32 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.515 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.657 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 CA-C-O 120.715 0.215 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.48 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.944 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.045 ' O ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.738 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.54 HG21 ' CB ' ' A' ' 44' ' ' SER . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 32' ' ' ASP . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.448 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.54 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.834 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.864 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.738 HG21 ' HB2' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 62' ' ' VAL . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.944 HG22 ' CE1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 120.801 0.25 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG21 ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 54' ' ' THR . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 7.0 m120 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.65 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.738 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.65 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HZ3' HG21 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 55' ' ' LEU . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 120.72 0.216 . . . . 0.0 111.875 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' THR . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.558 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 2.4 m-20 -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 44' ' ' SER . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.759 ' N ' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE2' ' O ' ' A' ' 2' ' ' PRO . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.704 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' N ' HD21 ' A' ' 52' ' ' LEU . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.704 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 8' ' ' VAL . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.536 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.82 0.258 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 65' ' ' LEU . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 51' ' ' LEU . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.678 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 61' ' ' THR . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.9 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.558 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.948 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.948 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.678 HD21 ' OG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 120.775 0.24 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 47' ' ' SER . 4.1 t60 -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.861 ' CA ' HG21 ' A' ' 54' ' ' THR . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 27' ' ' GLY . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.841 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.701 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.806 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.888 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.861 HG21 ' CA ' ' A' ' 23' ' ' LEU . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.742 0.226 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 61' ' ' THR . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.604 ' CE2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.735 ' C ' HD13 ' A' ' 33' ' ' ILE . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.566 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.663 ' CA ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 23' ' ' LEU . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 8' ' ' VAL . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 65' ' ' LEU . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.811 0.255 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' A' ' 65' ' ' LEU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' HD21 ' A' ' 65' ' ' LEU . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 58' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB2' HG21 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 27' ' ' GLY . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.773 ' H ' HD11 ' A' ' 51' ' ' LEU . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.63 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.773 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.54 HD23 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 5' ' ' GLU . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.784 0.243 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.809 ' CA ' HG21 ' A' ' 54' ' ' THR . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' H ' HG12 ' A' ' 29' ' ' VAL . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.512 ' OG ' HD11 ' A' ' 42' ' ' ILE . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.818 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.809 HG21 ' CA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 8' ' ' VAL . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.832 0.263 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' VAL . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 33' ' ' ILE . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.912 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.715 ' N ' HD21 ' A' ' 52' ' ' LEU . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.912 HD21 ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.894 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 23' ' ' LEU . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.548 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.438 0 CA-C-O 120.861 0.275 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.681 ' CD1' HG23 ' A' ' 62' ' ' VAL . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 61' ' ' THR . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG21 ' OG1' ' A' ' 58' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 22' ' ' VAL . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.522 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.795 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 40' ' ' VAL . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 33' ' ' ILE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' HG11 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.673 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.681 HG23 ' CD1' ' A' ' 6' ' ' PHE . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 65' ' ' LEU . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 CA-C-O 120.863 0.276 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' HD12 ' A' ' 65' ' ' LEU . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.92 HG21 HD13 ' A' ' 55' ' ' LEU . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.457 HG21 ' HZ1' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.822 ' CA ' HG21 ' A' ' 54' ' ' THR . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 47' ' ' SER . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.822 HG21 ' CA ' ' A' ' 23' ' ' LEU . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 HG21 ' A' ' 8' ' ' VAL . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 5' ' ' GLU . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 120.928 0.303 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' ILE . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.641 ' OG ' HD11 ' A' ' 65' ' ' LEU . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 21' ' ' ARG . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 19' ' ' VAL . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 42' ' ' ILE . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 48' ' ' MET . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.793 ' HA ' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.416 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.811 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD23 HG23 ' A' ' 62' ' ' VAL . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.83 HG23 HD23 ' A' ' 55' ' ' LEU . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' OG ' ' A' ' 7' ' ' SER . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.745 0.227 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.668 ' CE1' ' HH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' A' ' 44' ' ' SER . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.999 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.727 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.504 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.999 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.887 0.286 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 42' ' ' ILE . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.966 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.742 HD13 ' C ' ' A' ' 23' ' ' LEU . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 44' ' ' SER . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.917 ' H ' HD11 ' A' ' 51' ' ' LEU . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.966 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 23' ' ' LEU . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 CA-C-O 120.821 0.259 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.678 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.82 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.616 ' OG ' HD11 ' A' ' 65' ' ' LEU . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.939 HG21 ' OG1' ' A' ' 58' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.79 ' N ' HG21 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 27' ' ' GLY . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.793 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 33' ' ' ILE . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.636 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.785 HD23 HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.79 HG21 ' N ' ' A' ' 23' ' ' LEU . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 51' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.939 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.82 HG22 ' CE1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD11 ' OG ' ' A' ' 7' ' ' SER . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 120.648 0.187 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.641 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.957 ' O ' HG22 ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CB ' HG21 ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.641 ' HB3' ' CE1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.719 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.817 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.636 HG21 ' CB ' ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 8' ' ' VAL . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 62' ' ' VAL . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.84 0.267 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 54' ' ' THR . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 42' ' ' ILE . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HA ' ' A' ' 23' ' ' LEU . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 7' ' ' SER . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 CA-C-O 120.862 0.276 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.44 ' C ' ' OE2' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.643 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.848 HG11 HD22 ' A' ' 55' ' ' LEU . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.787 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.787 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD22 HG11 ' A' ' 8' ' ' VAL . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.817 0.257 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG21 ' OG1' ' A' ' 58' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.469 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' CA ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 6' ' ' PHE . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.849 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 65' ' ' LEU . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo . . . . . 0 N--CA 1.491 1.36 0 CA-C-O 120.704 0.21 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.745 ' CD1' HD12 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.635 ' C ' HD23 ' A' ' 23' ' ' LEU . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 33' ' ' ILE . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.658 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.618 ' C ' HD21 ' A' ' 52' ' ' LEU . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 1.009 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.009 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 50' ' ' THR . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.02 146.23 22.82 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.908 2.405 . . . . 0.0 112.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.48 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.944 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.045 ' O ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.738 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.54 HG21 ' CB ' ' A' ' 44' ' ' SER . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 32' ' ' ASP . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.448 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.54 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.834 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.864 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.738 HG21 ' HB2' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 62' ' ' VAL . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.944 HG22 ' CE1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.94 156.3 9.0 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -134.5 151.73 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 5.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.618 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.48 144.37 15.92 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.839 2.36 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLU . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG21 ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 54' ' ' THR . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 7.0 m120 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.65 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' OE2' ' O ' ' A' ' 1' ' ' MET . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.738 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.65 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HZ3' HG21 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 55' ' ' LEU . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.42 -170.87 34.6 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 46.5 mt -105.26 150.9 24.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.59 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.584 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 19.2 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -63.42 140.06 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.838 2.359 . . . . 0.0 111.875 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' THR . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.558 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 2.4 m-20 -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 44' ' ' SER . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.759 ' N ' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 1' ' ' MET . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.704 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' N ' HD21 ' A' ' 52' ' ' LEU . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.704 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 8' ' ' VAL . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.536 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.74 -168.05 26.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 68' ' ' GLU . 4.4 tp -103.99 149.22 25.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.607 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 9.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 51.3 Cg_endo -73.33 148.4 43.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.803 2.335 . . . . 0.0 112.045 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.442 ' HD1' ' HG ' ' A' ' 67' ' ' LEU . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 65' ' ' LEU . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 51' ' ' LEU . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.678 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 61' ' ' THR . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.9 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.558 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.948 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.948 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.678 HD21 ' OG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' C ' HD12 ' A' ' 67' ' ' LEU . . . 149.38 -179.28 26.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.4 mp -112.84 138.33 49.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.641 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 1' ' ' MET . 53.1 Cg_endo -75.32 148.46 34.1 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.309 2.006 . . . . 0.0 111.979 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 47' ' ' SER . 4.1 t60 -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.861 ' CA ' HG21 ' A' ' 54' ' ' THR . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 27' ' ' GLY . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.841 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.701 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.806 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.888 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.861 HG21 ' CA ' ' A' ' 23' ' ' LEU . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.91 -175.85 17.15 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -92.14 151.86 20.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.541 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' HB2' HD21 ' A' ' 67' ' ' LEU . 69.2 Cg_endo -77.83 147.85 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.04 2.493 . . . . 0.0 112.324 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' GLU . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 61' ' ' THR . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.604 ' CE2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.735 ' C ' HD13 ' A' ' 33' ' ' ILE . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.566 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.663 ' CA ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 23' ' ' LEU . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 8' ' ' VAL . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 65' ' ' LEU . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . 163.22 -172.29 39.16 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 68' ' ' GLU . 5.8 tt -121.27 129.78 53.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.423 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.73 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.54 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.69 151.64 24.61 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.864 2.376 . . . . 0.0 112.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' A' ' 65' ' ' LEU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' HD21 ' A' ' 65' ' ' LEU . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 58' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB2' HG21 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 27' ' ' GLY . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.773 ' H ' HD11 ' A' ' 51' ' ' LEU . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.63 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.773 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.54 HD23 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 5' ' ' GLU . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.32 160.05 8.31 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -90.28 152.29 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.602 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 1' ' ' MET . 47.9 Cg_exo -52.14 138.79 53.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.002 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.809 ' CA ' HG21 ' A' ' 54' ' ' THR . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' H ' HG12 ' A' ' 29' ' ' VAL . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.512 ' OG ' HD11 ' A' ' 42' ' ' ILE . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.818 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.809 HG21 ' CA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 8' ' ' VAL . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.82 178.28 15.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 68' ' ' GLU . 11.4 mt -89.5 140.44 29.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.537 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.6 Cg_endo -69.39 157.3 61.63 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.614 2.21 . . . . 0.0 112.22 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' VAL . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 33' ' ' ILE . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.912 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.715 ' N ' HD21 ' A' ' 52' ' ' LEU . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.912 HD21 ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.894 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 23' ' ' LEU . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.548 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.81 -175.93 18.18 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.37 151.98 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.63 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.584 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 67' ' ' LEU . 55.4 Cg_endo -74.39 147.44 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.18 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.681 ' CD1' HG23 ' A' ' 62' ' ' VAL . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 61' ' ' THR . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG21 ' OG1' ' A' ' 58' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 22' ' ' VAL . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.522 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.795 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 40' ' ' VAL . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 33' ' ' ILE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' HG11 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.673 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.681 HG23 ' CD1' ' A' ' 6' ' ' PHE . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 65' ' ' LEU . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.64 -160.44 22.24 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 67' ' ' LEU . 5.0 mp -118.23 144.62 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.12 158.73 45.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.718 2.278 . . . . 0.0 112.247 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' HD12 ' A' ' 65' ' ' LEU . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.92 HG21 HD13 ' A' ' 55' ' ' LEU . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.457 HG21 ' HZ1' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.822 ' CA ' HG21 ' A' ' 54' ' ' THR . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.487 ' OG ' HD21 ' A' ' 67' ' ' LEU . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.822 HG21 ' CA ' ' A' ' 23' ' ' LEU . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 HG21 ' A' ' 8' ' ' VAL . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 5' ' ' GLU . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 157.95 -176.93 34.9 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD21 ' OG ' ' A' ' 47' ' ' SER . 1.9 mt -104.65 150.38 24.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 110.388 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' CG ' ' O ' ' A' ' 68' ' ' GLU . 4.9 tt0 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.432 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 6.4 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_endo -68.42 152.86 75.01 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.543 2.162 . . . . 0.0 112.179 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 67' ' ' LEU . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.641 ' OG ' HD11 ' A' ' 65' ' ' LEU . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 21' ' ' ARG . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 19' ' ' VAL . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 42' ' ' ILE . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 1' ' ' MET . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 48' ' ' MET . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.793 ' HA ' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.416 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.811 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD23 HG23 ' A' ' 62' ' ' VAL . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.83 HG23 HD23 ' A' ' 55' ' ' LEU . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' OG ' ' A' ' 7' ' ' SER . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.85 169.78 12.42 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 4' ' ' HIS . 17.1 mt -93.53 147.66 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.631 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.649 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.2 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 1' ' ' MET . 25.1 Cg_exo -58.71 146.08 93.47 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.656 2.237 . . . . 0.0 111.828 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.668 ' CE1' ' HH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' A' ' 44' ' ' SER . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' A' ' 1' ' ' MET . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.999 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.727 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.504 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.999 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.67 -138.21 7.23 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.03 150.46 38.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.702 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.43 136.52 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 42' ' ' ILE . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.966 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.742 HD13 ' C ' ' A' ' 23' ' ' LEU . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 44' ' ' SER . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.917 ' H ' HD11 ' A' ' 51' ' ' LEU . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.966 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 23' ' ' LEU . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.04 -177.0 19.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -88.57 135.14 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.524 ' OE1' ' OXT' ' A' ' 68' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' CG ' ' O ' ' A' ' 1' ' ' MET . 1.8 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo -73.7 137.16 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.321 . . . . 0.0 112.104 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.446 ' ND1' HD23 ' A' ' 67' ' ' LEU . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.678 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.82 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.616 ' OG ' HD11 ' A' ' 65' ' ' LEU . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.939 HG21 ' OG1' ' A' ' 58' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.79 ' N ' HG21 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 27' ' ' GLY . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.793 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 33' ' ' ILE . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.636 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.785 HD23 HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.79 HG21 ' N ' ' A' ' 23' ' ' LEU . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 51' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.939 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.82 HG22 ' CE1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD11 ' OG ' ' A' ' 7' ' ' SER . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 160.93 -179.54 36.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 33.3 mt -101.13 136.69 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.567 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 2.5 tm-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' OE2' ' A' ' 45' ' ' GLU . 32.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.1 Cg_endo -74.93 144.99 31.2 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.621 2.214 . . . . 0.0 112.028 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.641 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.957 ' O ' HG22 ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CB ' HG21 ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' OE2' ' SD ' ' A' ' 1' ' ' MET . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.641 ' HB3' ' CE1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.719 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.817 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.636 HG21 ' CB ' ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 8' ' ' VAL . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 62' ' ' VAL . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 147.46 -170.74 28.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -129.2 141.54 51.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.257 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt0 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.594 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.9 ttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 1' ' ' MET . 20.7 Cg_exo -61.49 159.39 32.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.879 2.386 . . . . 0.0 112.068 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' HD23 ' A' ' 67' ' ' LEU . 2.9 t60 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 54' ' ' THR . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 42' ' ' ILE . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HA ' ' A' ' 23' ' ' LEU . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 7' ' ' SER . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.35 174.82 20.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' ND1' ' A' ' 4' ' ' HIS . 5.9 mt -89.13 140.45 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.559 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.1 139.22 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.241 . . . . 0.0 112.157 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.44 ' C ' ' OE2' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.643 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.848 HG11 HD22 ' A' ' 55' ' ' LEU . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.787 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.787 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD22 HG11 ' A' ' 8' ' ' VAL . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.24 149.17 4.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 68' ' ' GLU . 1.3 tt -101.49 129.35 47.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.708 0.29 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.615 ' N ' HD23 ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.07 147.8 88.55 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.824 2.35 . . . . 0.0 111.861 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG21 ' OG1' ' A' ' 58' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.469 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' CA ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 6' ' ' PHE . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.849 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 65' ' ' LEU . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.81 170.52 13.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -88.58 147.93 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.486 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.716 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.2 ttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 1' ' ' MET . 8.9 Cg_exo -67.5 136.41 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.623 2.215 . . . . 0.0 111.938 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.745 ' CD1' HD12 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.635 ' C ' HD23 ' A' ' 23' ' ' LEU . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 33' ' ' ILE . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.658 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.618 ' C ' HD21 ' A' ' 52' ' ' LEU . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 1.009 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.009 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 50' ' ' THR . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.7 -143.58 10.96 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.91 150.32 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.515 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.657 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 CA-C-O 120.715 0.215 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.48 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.944 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.045 ' O ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.738 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.54 HG21 ' CB ' ' A' ' 44' ' ' SER . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 32' ' ' ASP . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.448 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.54 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.834 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.864 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.738 HG21 ' HB2' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 62' ' ' VAL . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.944 HG22 ' CE1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 120.801 0.25 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG21 ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 54' ' ' THR . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 2.3 m-80 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.65 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.738 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.65 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HZ3' HG21 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 55' ' ' LEU . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 120.72 0.216 . . . . 0.0 111.875 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' THR . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 44' ' ' SER . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE2' ' O ' ' A' ' 2' ' ' PRO . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.704 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' N ' HD21 ' A' ' 52' ' ' LEU . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.704 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 8' ' ' VAL . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.536 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.82 0.258 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 65' ' ' LEU . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 51' ' ' LEU . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.678 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 61' ' ' THR . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.558 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.948 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.948 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.678 HD21 ' OG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 120.775 0.24 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.68 ' CD2' ' OG ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.861 ' CA ' HG21 ' A' ' 54' ' ' THR . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 27' ' ' GLY . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.841 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.68 ' OG ' ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.701 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.806 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.888 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.861 HG21 ' CA ' ' A' ' 23' ' ' LEU . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.742 0.226 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 61' ' ' THR . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.604 ' CE2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.735 ' C ' HD13 ' A' ' 33' ' ' ILE . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.566 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.663 ' CA ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 23' ' ' LEU . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 8' ' ' VAL . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 65' ' ' LEU . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.811 0.255 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' A' ' 65' ' ' LEU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' HD21 ' A' ' 65' ' ' LEU . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 58' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB2' HG21 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 27' ' ' GLY . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.773 ' H ' HD11 ' A' ' 51' ' ' LEU . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.63 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.54 HD23 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 5' ' ' GLU . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.784 0.243 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.809 ' CA ' HG21 ' A' ' 54' ' ' THR . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' H ' HG12 ' A' ' 29' ' ' VAL . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.512 ' OG ' HD11 ' A' ' 42' ' ' ILE . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.818 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.809 HG21 ' CA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 8' ' ' VAL . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.832 0.263 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' VAL . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 33' ' ' ILE . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.912 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.715 ' N ' HD21 ' A' ' 52' ' ' LEU . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.912 HD21 ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.894 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 23' ' ' LEU . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.548 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.438 0 CA-C-O 120.861 0.275 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.681 ' CD1' HG23 ' A' ' 62' ' ' VAL . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 61' ' ' THR . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG21 ' OG1' ' A' ' 58' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 22' ' ' VAL . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.6 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.795 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 40' ' ' VAL . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 33' ' ' ILE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' HG11 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.673 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.681 HG23 ' CD1' ' A' ' 6' ' ' PHE . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 65' ' ' LEU . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 CA-C-O 120.863 0.276 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' HD12 ' A' ' 65' ' ' LEU . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.92 HG21 HD13 ' A' ' 55' ' ' LEU . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.457 HG21 ' HZ1' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.822 ' CA ' HG21 ' A' ' 54' ' ' THR . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' A' ' 47' ' ' SER . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.822 HG21 ' CA ' ' A' ' 23' ' ' LEU . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 HG21 ' A' ' 8' ' ' VAL . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 5' ' ' GLU . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 120.928 0.303 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' ILE . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.641 ' OG ' HD11 ' A' ' 65' ' ' LEU . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 21' ' ' ARG . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 19' ' ' VAL . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 42' ' ' ILE . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 48' ' ' MET . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.793 ' HA ' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.416 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.811 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD23 HG23 ' A' ' 62' ' ' VAL . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.83 HG23 HD23 ' A' ' 55' ' ' LEU . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' OG ' ' A' ' 7' ' ' SER . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.745 0.227 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.668 ' CE1' ' HH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' A' ' 44' ' ' SER . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.999 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.727 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.504 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.999 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.887 0.286 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 42' ' ' ILE . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.966 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.742 ' C ' HD13 ' A' ' 23' ' ' LEU . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 44' ' ' SER . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.917 ' H ' HD11 ' A' ' 51' ' ' LEU . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.966 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 23' ' ' LEU . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 CA-C-O 120.821 0.259 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.678 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.82 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.616 ' OG ' HD11 ' A' ' 65' ' ' LEU . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.939 HG21 ' OG1' ' A' ' 58' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.79 ' N ' HG21 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 27' ' ' GLY . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.793 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 33' ' ' ILE . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.636 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.785 HD23 HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.79 HG21 ' N ' ' A' ' 23' ' ' LEU . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 51' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.939 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.82 HG22 ' CE1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD11 ' OG ' ' A' ' 7' ' ' SER . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 120.648 0.187 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.664 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.957 ' O ' HG22 ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CB ' HG21 ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.664 ' CB ' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.719 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.817 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.636 HG21 ' CB ' ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 8' ' ' VAL . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 62' ' ' VAL . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 N--CA 1.493 1.477 0 CA-C-O 120.84 0.267 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 54' ' ' THR . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 42' ' ' ILE . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HA ' ' A' ' 23' ' ' LEU . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.468 HG22 HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 7' ' ' SER . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 CA-C-O 120.862 0.276 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.44 ' C ' ' OE2' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.643 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.848 HG11 HD22 ' A' ' 55' ' ' LEU . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.796 ' N ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.787 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.787 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD22 HG11 ' A' ' 8' ' ' VAL . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.817 0.257 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG21 ' OG1' ' A' ' 58' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.469 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' CA ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 6' ' ' PHE . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.849 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 65' ' ' LEU . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo . . . . . 0 N--CA 1.491 1.36 0 CA-C-O 120.704 0.21 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.745 ' CD1' HD12 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 23' ' ' LEU . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 33' ' ' ILE . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.658 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.618 ' C ' HD21 ' A' ' 52' ' ' LEU . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 1.009 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.009 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 50' ' ' THR . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.02 146.23 22.82 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.908 2.405 . . . . 0.0 112.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -109.48 139.16 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.675 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 2.8 t-80 -123.81 128.1 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.48 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 9.6 pt-20 -111.12 129.71 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.944 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.229 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.9 112.53 24.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.625 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 61' ' ' THR . 4.7 p -131.12 128.2 61.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.21 115.12 21.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 13' ' ' GLY . 9.1 tmm? -66.38 115.85 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -110.85 -35.93 5.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.7 m -107.04 40.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.97 -54.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.95 -50.9 55.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.689 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.5 -43.22 13.75 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.808 -0.23 . . . . 0.0 111.384 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.44 -35.36 62.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.434 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -68.39 -44.73 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 110.16 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.41 70.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.045 ' O ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -61.94 -37.39 78.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.04 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -57.38 -34.25 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.157 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -57.46 -40.58 78.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.9 m -61.84 -19.62 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.186 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.738 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.8 tt -58.8 -33.66 70.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.118 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 17.9 m-80 -53.47 -37.01 62.27 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.487 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -68.18 -44.97 74.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.701 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.63 -57.03 0.89 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 67.91 22.03 73.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.54 HG21 ' CB ' ' A' ' 44' ' ' SER . 31.2 m -119.4 178.69 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -62.39 134.18 56.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.816 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.85 152.68 39.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -134.07 135.23 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.705 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.9 109.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.25 99.66 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.853 0.359 . . . . 0.0 110.537 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -61.2 -48.3 92.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.1 Cg_exo -52.37 -29.84 40.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.754 2.303 . . . . 0.0 112.358 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -102.85 -11.8 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.636 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 52.96 38.22 26.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.87 144.37 43.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 32' ' ' ASP . 4.1 t -123.62 120.97 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.571 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.08 114.34 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.448 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -127.13 137.59 57.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 1.6 pm0 -107.61 115.89 30.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.54 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.15 160.31 32.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.074 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -79.3 -12.02 59.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.565 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.52 -54.78 2.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 46' ' ' HIS . 57.9 m 59.58 137.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.4 ttt 70.4 54.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.834 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.5 t70 -179.04 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.098 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -41.15 26.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.663 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -65.11 -52.21 56.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.864 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.11 -51.02 67.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.5 78.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.476 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.738 HG21 ' HB2' ' A' ' 23' ' ' LEU . 65.5 m -69.55 -48.05 61.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 62' ' ' VAL . 5.8 mp -61.07 -45.7 93.68 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.672 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -73.58 -15.41 61.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.6 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -47.83 -52.24 19.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.292 -179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.86 12.38 6.19 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.47 77.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.04 145.74 39.95 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.346 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.97 138.4 57.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.944 HG22 ' CE1' ' A' ' 6' ' ' PHE . 5.4 p -129.47 129.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.697 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.427 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 48.9 m -138.49 120.89 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.517 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -86.84 117.67 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.454 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 mt -83.39 -18.45 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.94 156.3 9.0 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -134.5 151.73 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 5.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.618 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.48 144.37 15.92 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.839 2.36 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLU . 30.6 mttm -84.95 149.47 25.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.88 134.83 54.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.915 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.45 129.31 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -139.69 149.47 43.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.429 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t -124.78 116.09 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.345 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.0 p -130.39 123.16 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.217 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -77.55 114.16 16.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.2 mtp -66.6 117.25 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -110.11 -30.53 7.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.338 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 33.3 m -105.52 36.7 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.37 -49.88 0.01 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.0 -52.91 37.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.75 -44.05 12.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.651 0.263 . . . . 0.0 110.802 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.35 -33.21 58.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.3 -45.88 82.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 109.932 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 54' ' ' THR . 30.4 t -68.97 -36.9 76.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.968 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -56.88 -40.25 75.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.753 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 mtp85 -57.17 -39.93 76.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.034 0.445 . . . . 0.0 109.951 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG21 ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -57.99 -19.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.648 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 54' ' ' THR . 19.6 tp -58.39 -34.65 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.572 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 28' ' ' GLY . 2.3 m-80 -60.24 -36.44 77.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.902 0.382 . . . . 0.0 110.366 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -67.76 -44.57 77.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -74.85 -39.8 61.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.94 -55.27 1.52 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 66.01 17.55 65.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 -174.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -59.32 134.7 57.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.45 155.41 44.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.87 131.24 25.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.455 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.51 113.61 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.34 99.69 7.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.65 -46.84 93.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.409 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 39.7 Cg_exo -56.19 -28.05 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.142 2.561 . . . . 0.0 113.192 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.76 -7.06 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mttm 52.51 38.67 26.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.968 0.413 . . . . 0.0 109.964 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 154.46 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.382 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 120.65 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.632 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.01 113.21 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.65 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -127.65 137.59 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' OE2' ' O ' ' A' ' 1' ' ' MET . 17.3 tt0 -108.02 115.76 30.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 t -136.19 165.19 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.553 . . . . 0.0 111.334 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.08 -17.94 56.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.703 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 49' ' ' ASP . 4.4 t60 -94.54 -65.51 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.524 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.655 ' O ' ' CG ' ' A' ' 48' ' ' MET . 1.1 m 68.02 54.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.655 ' CG ' ' O ' ' A' ' 47' ' ' SER . 1.6 mmm 154.15 48.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.493 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.738 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -172.05 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.199 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -41.69 28.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.65 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -65.22 -55.79 16.48 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -57.11 -52.27 65.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.47 79.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.021 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.59 -50.94 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.56 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -64.62 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -15.16 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HZ3' HG21 ' A' ' 22' ' ' VAL . 12.4 tttt -52.47 -40.57 62.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.814 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.91 -31.35 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.74 16.06 9.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.71 147.08 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 p -69.97 120.17 15.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 55' ' ' LEU . 1.5 m -108.0 137.32 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.819 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -137.81 117.39 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -83.16 127.68 33.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.505 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.72 -46.49 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.42 -170.87 34.6 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 46.5 mt -105.26 150.9 24.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.59 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.584 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 19.2 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -63.42 140.06 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.838 2.359 . . . . 0.0 111.875 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -112.44 128.1 56.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -117.04 129.81 56.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.35 128.98 56.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.796 0.332 . . . . 0.0 110.573 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 139.33 53.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -113.4 117.17 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 61' ' ' THR . 9.2 p -130.59 136.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 114.55 17.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.783 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtt -71.16 117.02 12.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 111.237 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -35.93 5.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.818 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.21 33.92 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.666 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.89 -50.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.24 -52.82 40.78 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.694 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -83.51 -45.21 13.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.599 0.238 . . . . 0.0 110.512 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.94 -32.58 61.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.233 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 14.6 tp10 -62.53 -42.23 99.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.135 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 54' ' ' THR . 25.6 t -59.23 -36.48 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.357 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -33.32 65.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.969 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -55.55 -38.88 69.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.758 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.85 -20.58 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' THR . 1.4 tp -60.13 -33.96 72.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.306 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -63.18 -38.27 90.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.168 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -67.44 -44.76 77.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -80.67 -40.52 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.001 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.53 -52.61 1.12 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.558 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 64.11 25.63 69.72 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 44' ' ' SER . 12.3 m -119.71 -179.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -58.32 131.09 49.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -131.69 152.8 50.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -149.74 127.56 11.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -117.29 130.25 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.1 m-20 -107.81 99.98 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.149 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 1.1 mp -60.65 -54.24 56.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.767 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 11.5 Cg_endo -58.36 -26.27 76.61 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.307 2.005 . . . . 0.0 112.838 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -7.17 19.56 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp 52.81 38.93 27.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -124.46 162.78 23.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.281 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.24 121.84 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.6 t -118.81 112.89 20.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.164 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.827 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 1' ' ' MET . 3.5 tt0 -106.63 114.21 28.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.2 t -121.83 162.95 20.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.898 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.91 -34.42 59.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.395 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -101.85 -56.93 2.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.454 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m 63.89 160.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.704 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 1.8 ttt 71.8 34.74 1.5 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.694 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' N ' HD21 ' A' ' 52' ' ' LEU . 59.5 m-20 -163.12 -40.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.01 -37.07 40.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.704 ' CD1' ' H ' ' A' ' 48' ' ' MET . 1.0 OUTLIER -64.91 -53.33 48.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.198 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -64.21 -50.59 67.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -57.11 -48.35 78.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.645 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.654 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 11.5 m -69.67 -47.92 61.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.435 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 8' ' ' VAL . 89.8 mt -62.67 -36.96 84.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.546 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.181 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.7 tmtp? -33.02 -48.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.282 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.536 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -83.9 -17.78 39.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.03 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.74 16.34 36.72 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.789 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.56 147.04 39.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.576 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -59.04 137.54 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.137 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.25 135.63 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 111.276 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -137.64 115.97 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.156 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -77.51 129.11 35.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.562 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 2.4 mm? -85.35 -42.59 14.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.381 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.74 -168.05 26.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 68' ' ' GLU . 4.4 tp -103.99 149.22 25.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.607 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 9.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 51.3 Cg_endo -73.33 148.4 43.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.803 2.335 . . . . 0.0 112.045 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -89.13 142.19 27.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.442 ' HD1' ' HG ' ' A' ' 67' ' ' LEU . 41.1 m-70 -112.94 136.46 52.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.759 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 65' ' ' LEU . 91.8 mt-10 -108.74 129.65 55.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 51' ' ' LEU . 5.3 m-85 -141.37 139.74 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.675 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.678 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -106.12 111.93 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 61' ' ' THR . 7.6 p -129.62 121.31 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.45 115.43 18.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.09 116.42 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.517 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.95 -30.47 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.076 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.692 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -102.18 27.75 6.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.7 -49.73 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.25 -54.82 27.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.27 -42.49 15.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.26 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.5 -35.88 66.06 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -66.75 -45.26 79.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.74 77.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.837 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.65 -36.97 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.384 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.8 -34.15 67.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -56.77 -41.49 77.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.059 0.457 . . . . 0.0 109.983 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -18.22 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 54' ' ' THR . 7.1 tp -57.99 -33.28 68.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.115 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -53.51 -32.74 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.363 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -68.37 -45.12 73.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.61 -39.56 31.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.52 -64.32 0.8 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.98 66.67 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -122.81 -171.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.172 0.511 . . . . 0.0 110.765 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -56.43 129.29 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.646 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 21.1 p90 -148.91 152.7 36.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.825 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' C ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -162.71 122.92 2.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 1.6 pt -111.56 130.54 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.96 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -110.53 100.57 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.331 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.58 -46.48 97.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 35.0 Cg_exo -56.94 -29.93 84.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.96 2.44 . . . . 0.0 112.912 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.12 -5.14 21.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.252 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.8 mttm 55.02 38.86 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 7' ' ' SER . 7.4 mttt -135.75 154.15 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.233 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.84 122.26 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.98 114.23 28.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.742 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -124.16 136.04 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.36 -179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -111.33 115.91 30.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.51 162.01 36.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.132 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -82.17 -7.56 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.267 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.605 ' O ' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -86.71 -73.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER 89.69 105.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.399 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.558 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER 67.31 60.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.047 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.948 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -173.16 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.033 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.14 -48.31 13.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.045 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -66.34 -50.99 61.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.948 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -54.91 -48.38 73.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.33 -48.68 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.958 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 40.3 m -70.54 -48.33 55.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.9 mt -59.63 -44.97 93.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.471 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -62.47 -34.2 76.36 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.117 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.5 tmtt? -34.76 -48.82 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.301 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.57 -17.32 39.18 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.842 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 99.06 16.1 31.36 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.72 140.41 42.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.616 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 t -65.14 139.45 58.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.183 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.13 134.35 64.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.71 132.75 33.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 7.8 p90 -86.14 134.97 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.678 HD21 ' OG ' ' A' ' 7' ' ' SER . 23.6 mt -98.11 -35.05 10.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.552 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' C ' HD12 ' A' ' 67' ' ' LEU . . . 149.38 -179.28 26.3 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 67' ' ' LEU . 7.4 mp -112.84 138.33 49.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.641 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 1' ' ' MET . 53.1 Cg_endo -75.32 148.46 34.1 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.309 2.006 . . . . 0.0 111.979 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -96.88 149.54 21.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.68 ' CD2' ' OG ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -112.5 126.46 55.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.57 129.61 47.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -143.31 139.22 30.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.5 122.36 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.37 121.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.628 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 113.45 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.0 mtm -67.47 116.32 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.996 0.427 . . . . 0.0 111.159 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.9 m -110.23 -34.65 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.626 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.0 m -105.37 31.34 4.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.048 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.47 -51.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.71 -52.33 43.58 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.07 -44.87 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.559 0.218 . . . . 0.0 111.097 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.28 -34.46 64.12 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 3.3 tt0 -65.83 -45.84 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.01 74.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' CG1' ' O ' ' A' ' 54' ' ' THR . 2.6 t -64.64 -35.9 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.228 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -56.28 -34.15 66.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -60.72 -39.82 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 t -58.07 -19.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.861 ' CA ' HG21 ' A' ' 54' ' ' THR . 0.7 OUTLIER -58.47 -34.62 71.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.647 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -55.4 -33.76 63.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.896 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -68.46 -44.92 73.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -80.25 -40.11 27.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.206 -179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -94.32 -48.86 2.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.24 24.96 38.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 27' ' ' GLY . 28.0 m -121.82 -178.75 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 0.0 110.702 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -71.57 138.09 48.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.428 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.49 162.03 36.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.75 136.96 33.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.135 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -118.76 127.24 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.045 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -114.69 99.88 7.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -61.51 -45.83 94.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.229 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 24.7 Cg_exo -59.14 -30.4 93.04 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.005 2.47 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.09 -7.25 20.37 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 mttp 52.76 38.95 27.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.315 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -124.8 161.38 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.71 120.91 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.58 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -114.56 114.79 26.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.04 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.841 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -124.35 137.33 57.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.495 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 116.09 31.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -131.37 164.94 24.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.233 0.539 . . . . 0.0 111.498 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 4.0 mt-10 -69.55 -20.52 63.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.672 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -104.09 -59.84 1.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.903 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.68 ' OG ' ' CD2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER 70.44 116.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 84.82 65.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.701 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.8 OUTLIER 171.56 -40.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.675 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.806 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.77 -36.59 42.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.298 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' A' ' 42' ' ' ILE . 7.6 mp -65.07 -52.83 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.888 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -54.49 -51.95 63.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.83 77.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.771 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.861 HG21 ' CA ' ' A' ' 23' ' ' LEU . 1.9 m -70.46 -50.46 37.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.011 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.6 -45.38 90.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 57' ' ' LYS . 5.5 tptp -66.41 -20.09 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.897 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -40.23 -42.5 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.122 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -35.79 21.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.02 15.64 6.59 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.28 147.21 38.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.75 126.22 30.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.45 152.16 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.472 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -137.81 114.2 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.41 121.29 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.344 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -86.4 -37.48 18.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.845 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.91 -175.85 17.15 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -92.14 151.86 20.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.541 179.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' HB2' HD21 ' A' ' 67' ' ' LEU . 69.2 Cg_endo -77.83 147.85 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 123.04 2.493 . . . . 0.0 112.324 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' GLU . 3.4 mtmt -90.58 150.49 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 0.7 OUTLIER -114.01 131.12 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.601 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.41 129.21 53.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.406 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.3 m-85 -144.25 140.91 29.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -124.25 119.02 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.779 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 61' ' ' THR . 2.0 p -130.71 133.94 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 121.9 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.06 117.09 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.033 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -109.74 -26.19 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.937 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -97.98 31.55 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.403 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.95 -49.47 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.2 -53.74 34.56 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.79 -42.28 14.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.406 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.39 -32.9 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.413 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -62.46 -44.11 97.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.383 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.62 69.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.004 0.43 . . . . 0.0 110.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 54' ' ' THR . 37.4 t -64.03 -36.6 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -56.98 -37.94 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.791 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtm180 -66.67 -40.22 88.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.123 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.52 -19.29 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.6 OUTLIER -58.65 -34.66 71.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 111.071 -178.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.3 p30 -59.46 -30.36 68.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.788 0.327 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -66.31 -44.97 81.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -77.93 -39.91 41.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.868 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 -58.43 1.01 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 71.49 32.37 64.8 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.08 -174.65 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.642 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -50.21 130.01 22.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.823 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.604 ' CE2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -146.05 152.83 39.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.368 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.735 ' C ' HD13 ' A' ' 33' ' ' ILE . 2.9 m-20 -160.57 134.57 7.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -117.9 128.56 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.98 100.47 9.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.57 -44.55 95.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.186 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 31.5 Cg_exo -55.72 -30.74 77.16 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.835 2.356 . . . . 0.0 112.908 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.3 -8.95 17.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.075 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.5 mttp 56.36 39.08 30.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.89 0.376 . . . . 0.0 110.587 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -128.91 166.38 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' PHE . 9.3 t -138.74 121.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.663 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.57 114.53 25.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.847 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.566 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -127.0 136.69 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.543 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -108.05 115.03 29.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.2 p -138.44 164.78 28.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.255 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.14 -34.16 74.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.977 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.561 ' O ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -87.98 -66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.643 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.1 OUTLIER 61.06 124.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.862 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttt 87.78 44.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.663 ' CA ' HD21 ' A' ' 52' ' ' LEU . 3.8 t70 -173.45 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.222 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.75 -35.22 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.4 mp -65.09 -51.13 63.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.499 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.858 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.7 -52.54 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.82 87.02 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 23' ' ' LEU . 59.9 p -68.54 -50.49 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 8' ' ' VAL . 86.0 mt -63.54 -44.77 93.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' N ' ' A' ' 59' ' ' GLY . 23.1 mmtt -62.23 -22.7 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 56' ' ' LYS . 19.9 mmtt -33.74 -51.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.955 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.39 -15.59 45.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.853 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 98.81 16.25 31.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.31 133.9 41.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.862 0.363 . . . . 0.0 110.499 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -59.72 135.82 57.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.035 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.92 147.58 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -137.19 117.58 13.69 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.914 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 19.1 t80 -78.17 106.28 9.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.27 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 65' ' ' LEU . 4.3 mt -79.53 -51.36 9.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 64' ' ' TYR . . . 163.22 -172.29 39.16 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 68' ' ' GLU . 5.8 tt -121.27 129.78 53.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.423 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.73 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.54 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.69 151.64 24.61 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.864 2.376 . . . . 0.0 112.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -114.87 124.79 52.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.297 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.5 133.17 56.29 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.624 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' A' ' 65' ' ' LEU . 3.1 mp0 -115.36 128.6 56.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.175 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD1' HD22 ' A' ' 51' ' ' LEU . 1.2 m-85 -125.75 139.24 53.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' HD21 ' A' ' 65' ' ' LEU . 30.8 m -100.73 111.0 23.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.254 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.1 p -130.4 125.02 58.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.264 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 113.28 21.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 81.9 mtp -78.43 116.74 19.04 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.318 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -110.39 -27.79 8.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.716 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.0 m -99.31 30.7 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.377 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.79 -52.16 0.01 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.66 -54.24 30.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.68 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -80.95 -45.42 16.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 0.0 110.589 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.43 -32.62 62.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.819 0.342 . . . . 0.0 110.346 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 tt0 -62.41 -45.39 93.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.447 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.87 67.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 58' ' ' THR . 52.9 t -61.87 -35.83 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.537 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -55.94 -39.94 72.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.06 -20.3 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB2' HG21 ' A' ' 54' ' ' THR . 44.0 tp -59.8 -34.4 72.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.597 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.615 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 22.0 t-20 -67.32 -35.45 79.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.628 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -66.39 -44.39 83.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.767 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.9 -40.18 25.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.22 -46.06 1.92 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.465 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.615 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.27 27.38 46.63 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 27' ' ' GLY . 17.6 m -119.57 178.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 110.507 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -65.19 135.98 56.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.92 167.89 21.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.156 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -147.0 130.1 16.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.103 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.58 113.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -105.9 100.34 9.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.071 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -60.43 -51.37 80.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.233 -179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.2 Cg_exo -54.46 -29.3 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.959 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.78 -9.12 20.26 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mttm 52.59 38.84 26.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.872 0.367 . . . . 0.0 110.209 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -131.74 157.97 42.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.76 121.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.754 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.04 114.86 29.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -126.51 136.65 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.252 0.549 . . . . 0.0 112.163 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.95 115.75 30.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -130.62 164.48 24.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 111.71 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -73.93 -34.81 64.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.445 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -89.23 -55.39 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER 60.32 119.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.675 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.773 ' H ' HD11 ' A' ' 51' ' ' LEU . 4.0 tpt 91.25 63.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.531 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.63 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 170.62 -42.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.349 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.0 -35.45 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.288 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -64.86 -52.27 57.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.7 -49.52 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.76 79.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.639 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 8.9 m -69.39 -49.49 54.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 111.612 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.54 HD23 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mp -63.25 -36.44 83.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.436 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' GLY . 6.9 mtpm? -71.45 -23.95 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.642 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.14 -46.94 4.5 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.966 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -7.04 59.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.872 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 86.7 16.3 61.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.87 142.0 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.649 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -59.58 138.65 57.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.353 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.26 133.32 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.912 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -136.68 124.11 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -87.7 140.36 29.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.163 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 5' ' ' GLU . 11.2 mt -98.73 -34.5 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.32 160.05 8.31 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -90.28 152.29 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.602 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 1' ' ' MET . 47.9 Cg_exo -52.14 138.79 53.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.002 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -93.02 148.38 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 47' ' ' SER . 5.6 t-160 -115.23 130.95 57.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.353 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -106.96 129.55 54.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -131.5 139.56 49.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 110.45 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.051 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -130.36 120.14 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.848 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.34 116.17 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.035 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.1 mtt -66.82 117.38 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.8 p -109.52 -30.05 8.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.094 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.6 m -105.32 33.04 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -16.28 -51.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -54.43 28.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -84.63 -41.71 16.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.67 0.272 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.81 -31.89 59.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.74 -42.27 98.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.59 -28.89 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.953 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' O ' ' A' ' 54' ' ' THR . 48.8 t -60.59 -37.21 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.159 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 21' ' ' ARG . 52.6 mtp85 -60.9 -39.7 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.085 0.469 . . . . 0.0 109.747 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.72 -19.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.695 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.809 ' CA ' HG21 ' A' ' 54' ' ' THR . 48.5 tp -58.98 -34.61 72.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.428 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 12.8 m-20 -59.52 -36.04 75.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -68.12 -45.24 74.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -76.38 -40.4 51.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.21 -61.08 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 72.17 29.03 67.16 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -130.29 -171.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.162 0.506 . . . . 0.0 110.715 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' H ' HG12 ' A' ' 29' ' ' VAL . 33.2 mttt -62.26 124.27 20.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 159.43 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.76 139.84 21.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.647 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.53 118.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.88 99.58 7.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.612 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.85 -49.21 86.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.409 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.9 Cg_exo -52.6 -30.17 44.11 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -103.0 -3.86 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.141 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.37 38.76 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.072 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.61 167.4 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.4 t -139.53 121.08 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 5.0 t -116.07 114.01 23.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.374 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -127.77 138.52 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.031 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.33 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.512 ' OG ' HD11 ' A' ' 42' ' ' ILE . 58.2 m -141.83 164.82 29.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.344 0.593 . . . . 0.0 111.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.49 -34.76 77.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 47' ' ' SER . 96.3 m-70 -76.37 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 48' ' ' MET . 3.2 p 86.24 107.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.279 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.639 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.7 ttm 98.35 52.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.31 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.818 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 174.07 -37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.617 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.44 -42.28 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.79 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.82 -48.53 71.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.289 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -63.19 -52.32 62.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.73 82.75 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.532 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.809 HG21 ' CA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -69.19 -49.41 56.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.316 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 8' ' ' VAL . 85.2 mt -63.63 -39.69 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.761 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . 55.7 mtpt -66.99 -22.89 65.89 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.2 mmtt -34.98 -50.99 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.393 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.18 -17.26 40.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.286 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 96.16 16.92 36.29 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.308 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.89 148.28 40.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -58.86 125.47 23.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.705 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.23 132.42 57.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.494 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.56 125.52 24.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -94.16 132.68 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mt -94.3 -35.77 12.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.82 178.28 15.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 68' ' ' GLU . 11.4 mt -89.5 140.44 29.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.537 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.6 Cg_endo -69.39 157.3 61.63 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.614 2.21 . . . . 0.0 112.22 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.58 145.17 25.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.457 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.463 ' NE2' ' CG ' ' A' ' 48' ' ' MET . 3.9 t60 -115.94 129.34 56.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.47 131.09 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.037 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.31 115.18 29.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.443 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 p -131.53 118.3 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.251 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.1 113.69 15.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.579 ' CG ' ' O ' ' A' ' 10' ' ' MET . 10.0 ptt? -78.09 115.85 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.253 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 p -110.86 -29.93 7.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.5 m -99.76 28.92 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.602 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.39 -54.0 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -62.78 -52.37 48.88 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -82.86 -45.32 14.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.592 0.234 . . . . 0.0 110.499 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -56.07 -32.72 64.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.323 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tm-20 -62.19 -45.25 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.274 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.86 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 109.829 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 54' ' ' THR . 54.6 t -63.25 -36.28 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.447 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 m -56.12 -34.12 65.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.164 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.25 -40.02 76.78 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.82 -20.36 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 23' ' ' LEU . 3.3 tm? -60.07 -40.93 91.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 28' ' ' GLY . 26.6 t30 -58.39 -38.67 77.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.066 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.01 -44.6 76.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.74 -40.41 55.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.271 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.41 -54.49 1.01 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.839 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 68.12 26.13 74.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.26 -176.58 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.578 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 129.94 38.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.284 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 p90 -138.33 168.01 20.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' OD1' ' C ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.82 123.37 4.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.222 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' VAL . 20.2 tt -117.91 124.63 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.41 106.06 15.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -60.49 -53.51 63.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.4 Cg_endo -60.98 -24.51 79.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.371 2.048 . . . . 0.0 113.161 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.75 -9.28 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.84 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 52.34 38.35 24.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 109.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -130.61 144.19 51.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.226 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 33' ' ' ILE . 2.3 t -132.25 120.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.345 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.86 114.5 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.912 ' CG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.66 137.92 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.992 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -106.79 116.22 31.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.55 164.06 19.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.106 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -72.99 -25.68 61.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.43 -58.44 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.94 153.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.573 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 5.9 mtt 68.01 34.05 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.715 ' N ' HD21 ' A' ' 52' ' ' LEU . 20.8 m-20 -160.25 -37.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.12 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.88 -39.27 35.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.159 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.912 HD21 ' CG2' ' A' ' 42' ' ' ILE . 3.8 mp -65.02 -50.45 66.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.894 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.47 -52.35 63.92 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.6 79.51 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.156 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 23' ' ' LEU . 42.9 m -70.14 -50.88 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -63.88 -44.56 92.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.346 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -67.54 -19.33 65.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.31 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' THR . 3.5 tmtp? -44.19 -47.82 9.21 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.548 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.4 -13.14 53.02 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.594 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 94.89 16.09 43.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.84 145.29 40.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.83 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.5 m -61.65 132.6 53.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 6' ' ' PHE . 3.7 p -121.91 131.93 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.564 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 2.3 t -135.18 121.39 20.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -83.18 135.1 34.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.258 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.43 -40.49 7.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.69 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.81 -175.93 18.18 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.37 151.98 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.63 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.584 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 67' ' ' LEU . 55.4 Cg_endo -74.39 147.44 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.18 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -102.03 148.44 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 42' ' ' ILE . 11.9 t-160 -114.29 126.11 54.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.69 131.75 55.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.74 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.681 ' CD1' HG23 ' A' ' 62' ' ' VAL . 5.9 p90 -136.94 146.16 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.21 121.38 44.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 61' ' ' THR . 9.0 p -130.08 136.57 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.02 113.57 20.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -66.4 116.83 7.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 -41.38 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 5.2 m -105.15 29.66 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.412 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.63 -50.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.29 -52.34 44.82 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.58 -44.45 12.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.714 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.62 -32.59 59.18 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.426 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.54 -45.25 93.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.446 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.74 -29.11 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.957 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG21 ' OG1' ' A' ' 58' ' ' THR . 42.3 t -62.65 -37.45 79.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 m -57.21 -35.96 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.99 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -57.03 -39.41 74.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 22' ' ' VAL . 3.1 t -57.09 -19.42 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.6 tt -59.11 -34.31 71.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.68 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.6 ' ND2' ' N ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -54.55 -34.57 62.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.869 0.366 . . . . 0.0 110.64 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -67.81 -45.13 75.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -78.86 -40.54 32.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.372 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.71 -58.81 0.83 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 65.7 38.23 94.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 30' ' ' LYS . 1.5 t -127.56 -168.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.103 0.478 . . . . 0.0 110.738 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.795 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -85.57 139.54 31.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.79 162.53 39.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.848 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.79 129.53 28.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 40' ' ' VAL . 1.2 pt -115.47 112.31 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.74 100.82 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.392 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -60.34 -44.0 94.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 48.2 Cg_exo -52.41 -27.41 31.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.99 2.46 . . . . 0.0 113.131 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -105.03 -4.36 22.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 52.49 36.67 20.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.384 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.54 153.99 48.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 33' ' ' ILE . 71.1 t -130.71 125.76 59.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.6 t -105.82 114.18 28.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.199 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -123.56 135.88 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.89 116.79 32.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.14 163.54 24.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 110.996 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.88 -9.47 59.49 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.57 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.663 ' CD2' ' OD2' ' A' ' 49' ' ' ASP . 1.3 t-80 -113.6 -53.29 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.511 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' MET . 14.5 m 65.63 56.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 160.76 61.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.221 0.534 . . . . 0.0 110.136 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.663 ' OD2' ' CD2' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 169.23 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.662 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -47.67 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -67.59 -55.81 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' HG11 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -58.88 -48.31 81.85 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.47 75.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.013 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.631 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 91.9 m -69.43 -51.24 38.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.3 mp -64.7 -43.99 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.963 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . 12.8 mmtm -59.54 -28.58 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.294 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -42.51 -45.64 4.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.543 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.673 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.89 -11.41 55.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.391 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 95.03 15.59 44.54 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.96 130.19 35.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -75.05 113.24 12.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.681 HG23 ' CD1' ' A' ' 6' ' ' PHE . 12.2 p -108.49 145.49 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -137.78 124.78 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.635 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' NE2' ' A' ' 4' ' ' HIS . 2.9 p90 -85.33 136.77 33.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 65' ' ' LEU . 79.3 mt -101.23 -24.29 14.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.669 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.64 -160.44 22.24 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.0 mp -118.23 144.62 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.12 158.73 45.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.718 2.278 . . . . 0.0 112.247 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -92.64 133.03 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.26 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -115.26 142.96 45.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.742 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' HD12 ' A' ' 65' ' ' LEU . 11.5 mt-10 -102.8 129.3 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 51' ' ' LEU . 1.4 t80 -143.91 139.4 29.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.397 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.73 124.11 43.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.181 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.92 HG21 HD13 ' A' ' 55' ' ' LEU . 74.0 t -130.23 124.96 58.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 4.0 t0 -78.04 117.36 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.65 116.64 7.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 0.0 110.959 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.2 -37.81 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.965 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.4 m -107.42 35.04 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.551 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.37 -53.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.72 -54.63 27.39 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -81.23 -42.86 20.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.323 . . . . 0.0 110.374 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.44 -33.42 63.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.129 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' OG ' ' A' ' 20' ' ' SER . 2.6 tm-20 -63.62 -45.33 90.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.105 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -28.93 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.4 t -62.14 -36.75 76.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 17' ' ' GLU . 63.0 p -56.31 -41.99 76.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.31 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -57.14 -40.76 77.81 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.457 HG21 ' HZ1' ' A' ' 57' ' ' LYS . 61.3 t -59.92 -18.69 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.495 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.822 ' CA ' HG21 ' A' ' 54' ' ' THR . 14.3 tp -58.1 -34.57 70.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 19.7 m-80 -59.57 -31.38 69.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -68.05 -45.16 74.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.691 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -78.11 -40.17 39.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.406 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.26 -62.86 0.8 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 75.24 28.58 61.74 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.04 -170.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.52 . . . . 0.0 110.851 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -57.95 120.39 8.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.795 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -139.39 153.55 47.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.559 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -155.14 137.55 14.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.81 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 m-20 -114.83 100.18 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -60.9 -45.43 96.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.3 Cg_exo -57.91 -29.68 87.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.791 2.327 . . . . 0.0 112.181 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -101.03 -10.41 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.0 mttt 52.69 38.34 25.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.81 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -137.13 156.49 48.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.321 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.75 120.74 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.778 0.323 . . . . 0.0 110.648 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.13 114.45 28.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.817 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 42' ' ' ILE . 1.1 tt -123.27 127.23 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.399 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -109.59 115.46 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -140.57 165.79 26.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.191 0.52 . . . . 0.0 111.41 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.29 -32.82 74.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.396 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -107.47 -53.67 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.241 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.487 ' OG ' HD21 ' A' ' 67' ' ' LEU . 17.7 p 45.12 67.04 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.089 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.43 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 3.3 ttt -178.95 47.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 110.277 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 5.4 p-10 171.05 -29.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.599 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 -36.02 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.404 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -65.8 -51.05 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.115 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.85 -51.99 48.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.53 78.19 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.822 HG21 ' CA ' ' A' ' 23' ' ' LEU . 7.2 m -68.93 -49.73 55.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.515 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 HG21 ' A' ' 8' ' ' VAL . 18.1 mt -61.74 -41.59 97.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.748 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 59' ' ' GLY . 3.1 tptp -62.15 -28.68 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.972 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -29.17 -49.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.185 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.7 -21.44 30.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.257 -179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 102.71 17.13 20.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.341 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -74.94 140.08 43.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.963 0.411 . . . . 0.0 110.707 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.81 135.33 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.24 155.06 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 t -137.57 112.8 9.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 7.3 t80 -90.98 106.61 18.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 5' ' ' GLU . 54.7 mt -83.59 -51.08 7.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 157.95 -176.93 34.9 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD21 ' OG ' ' A' ' 47' ' ' SER . 1.9 mt -104.65 150.38 24.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 110.388 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' CG ' ' O ' ' A' ' 68' ' ' GLU . 4.9 tt0 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.432 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 6.4 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_endo -68.42 152.86 75.01 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.543 2.162 . . . . 0.0 112.179 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -87.83 146.9 25.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.388 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 67' ' ' LEU . 1.3 t-160 -116.81 132.14 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.68 128.76 51.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.141 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 147.3 49.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.169 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.641 ' OG ' HD11 ' A' ' 65' ' ' LEU . 3.5 m -106.34 113.85 27.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -131.14 130.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.63 113.09 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -72.83 116.78 13.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -110.52 -39.34 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.904 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -96.41 35.7 1.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -19.02 -52.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.43 -51.64 50.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -84.1 -44.65 13.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 0.0 110.646 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.82 -33.68 61.87 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.47 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -65.02 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.84 68.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.06 0.457 . . . . 0.0 110.056 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.8 t -62.99 -37.03 78.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -56.5 -33.46 66.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 21' ' ' ARG . 34.3 mtm180 -56.28 -42.45 77.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.397 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 19' ' ' VAL . 1.2 m -58.92 -19.72 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 42' ' ' ILE . 36.4 tp -58.54 -34.52 71.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.37 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 45.9 m-20 -56.27 -37.52 69.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -68.11 -44.8 75.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -75.77 -40.72 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.324 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 -65.01 0.78 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 71.57 30.81 66.05 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -134.43 -171.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.251 0.548 . . . . 0.0 110.909 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' H ' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.35 133.59 49.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.83 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -148.7 159.31 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.481 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.54 135.53 15.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.848 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.63 114.38 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 99.95 9.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -61.65 -54.03 55.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.258 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 13.0 Cg_endo -59.56 -28.73 88.17 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.347 2.031 . . . . 0.0 113.111 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.17 -8.24 25.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 53.82 39.25 30.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.449 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -130.09 153.49 48.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.82 120.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.61 113.86 27.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.847 HD12 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -127.39 134.23 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.167 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 1' ' ' MET . 15.7 tt0 -110.52 115.31 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -129.07 163.99 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.235 0.541 . . . . 0.0 111.189 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -86.67 -17.93 32.53 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.392 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -92.87 -52.47 4.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 48' ' ' MET . 19.8 m 58.73 115.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.261 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.558 ' CB ' ' O ' ' A' ' 47' ' ' SER . 3.6 tpp 86.85 61.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.932 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.793 ' HA ' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER 173.87 -42.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.416 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.55 -38.85 39.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -64.99 -48.67 73.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.93 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.811 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.69 -49.39 77.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.38 79.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.749 0.309 . . . . 0.0 111.195 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 23' ' ' LEU . 87.4 m -68.88 -50.05 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD23 HG23 ' A' ' 62' ' ' VAL . 5.2 mp -63.7 -45.33 90.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.091 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -73.21 -10.28 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.543 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.37 -52.42 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.18 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.45 9.71 12.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.791 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.65 15.82 77.76 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.42 38.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 t -64.18 133.43 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.83 HG23 HD23 ' A' ' 55' ' ' LEU . 9.6 p -120.11 135.52 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.965 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 t -137.95 120.96 16.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.437 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.595 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -77.88 120.59 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' OG ' ' A' ' 7' ' ' SER . 11.1 mt -78.42 -38.4 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.85 169.78 12.42 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 4' ' ' HIS . 17.1 mt -93.53 147.66 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.631 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.649 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.2 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 1' ' ' MET . 25.1 Cg_exo -58.71 146.08 93.47 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.656 2.237 . . . . 0.0 111.828 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -99.76 123.02 43.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.668 ' CE1' ' HH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -112.96 137.37 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.413 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -114.08 128.69 56.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.481 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.0 139.36 46.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.809 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 t -112.13 116.55 30.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 55' ' ' LEU . 11.7 p -130.93 132.06 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.1 113.55 24.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.68 116.79 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.917 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 m -110.25 -41.11 4.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.084 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.2 m -96.43 35.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.462 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.26 -49.32 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.51 -53.81 33.13 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.704 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -86.03 -41.98 14.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.704 0.288 . . . . 0.0 110.816 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.92 -33.88 62.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.25 -45.69 83.59 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.687 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.81 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.5 t -66.29 -37.26 79.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.354 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.42 -39.81 77.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -62.1 -39.93 94.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 109.77 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -57.96 -17.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.605 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 39.2 tp -57.4 -33.77 68.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.875 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -53.81 -30.63 45.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.232 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -68.11 -46.27 71.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.007 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -82.01 -40.43 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.696 0.284 . . . . 0.0 111.177 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.15 -55.42 1.05 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.72 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.94 65.48 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' A' ' 44' ' ' SER . 31.0 m -120.85 176.47 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -59.46 138.64 57.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 10.5 p90 -144.24 159.87 41.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.679 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 31' ' ' TYR . 32.6 m-20 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.34 121.55 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.37 100.08 7.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.386 . . . . 0.0 110.437 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 36' ' ' PRO . 2.1 mt -61.42 -53.76 59.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.996 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -64.02 -20.8 68.21 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.418 2.079 . . . . 0.0 113.028 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -103.95 -12.56 16.77 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm 52.56 38.66 26.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.997 0.427 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -135.85 149.89 49.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 120.45 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.515 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 t -98.39 113.83 25.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -127.95 130.96 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.748 -179.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.65 115.93 30.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.5 t -121.68 164.61 17.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.241 0.543 . . . . 0.0 111.626 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' A' ' 1' ' ' MET . 6.7 mm-40 -79.8 -25.58 40.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -113.48 -47.09 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.085 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER 48.04 166.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.864 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.999 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 71.13 60.3 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.727 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER 161.3 -40.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.146 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.504 ' OG1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.92 -33.66 45.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.999 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -65.15 -50.43 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -67.32 -43.57 81.29 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.74 78.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.795 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 89.0 m -69.01 -47.84 64.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.8 mp -63.79 -46.46 85.06 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.53 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -73.83 -8.58 56.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.319 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -55.62 -49.39 72.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.428 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -0.93 55.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.881 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.61 58.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.75 144.29 41.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.9 129.18 38.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.22 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.768 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 t -127.11 130.24 49.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.394 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' HH ' ' CE1' ' A' ' 4' ' ' HIS . 0.9 OUTLIER -78.21 114.66 17.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.498 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.1 mm? -82.22 -50.38 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.67 -138.21 7.23 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.03 150.46 38.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.702 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.43 136.52 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.961 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.72 139.22 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.457 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 42' ' ' ILE . 4.1 t-160 -123.7 126.79 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.587 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -108.24 135.05 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.357 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.966 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -137.18 139.75 41.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.2 118.35 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.204 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 55' ' ' LEU . 61.8 t -131.13 129.05 62.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.331 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 119.59 26.62 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 116.21 7.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.135 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.0 m -110.59 -36.8 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.669 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -107.51 33.6 3.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.99 -56.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -51.13 54.28 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -81.27 -44.55 17.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.7 -33.18 60.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.734 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 10.8 tt0 -63.12 -45.56 91.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.22 68.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 109.701 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 54' ' ' THR . 3.2 t -67.65 -36.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.348 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -34.65 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.75 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -39.32 73.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 0.0 109.999 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.29 -19.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.742 ' C ' HD13 ' A' ' 23' ' ' LEU . 3.2 tm? -59.02 -34.45 71.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.991 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 28' ' ' GLY . 12.6 t-20 -62.88 -40.49 97.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -66.99 -44.63 79.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.453 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -74.28 -41.43 61.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.49 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.22 -53.32 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.776 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.23 31.54 80.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 44' ' ' SER . 4.5 m -127.42 -176.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.74 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.94 129.48 39.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -134.38 159.8 39.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -144.26 131.85 21.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.61 116.91 52.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.699 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.56 99.83 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.436 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -61.36 -45.93 94.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.9 Cg_exo -55.59 -30.19 73.59 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.952 2.434 . . . . 0.0 112.766 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -103.74 -10.32 18.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 52.81 38.69 27.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.115 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 152.06 48.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.314 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.99 120.87 60.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.59 114.16 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.793 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -126.97 134.19 66.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 10.2 tt0 -109.58 115.8 30.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 47' ' ' SER . 4.7 p -130.38 164.59 24.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.69 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.39 -21.66 42.07 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -104.24 -53.93 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' MET . 21.9 m 61.81 127.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.917 ' H ' HD11 ' A' ' 51' ' ' LEU . 12.2 ttm 87.23 61.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.942 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 3.6 p-10 169.85 -42.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.11 -36.76 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.367 -179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.966 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -65.17 -54.76 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -65.06 -45.82 83.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -56.82 -48.35 78.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.196 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 23' ' ' LEU . 15.8 m -70.1 -51.29 32.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.001 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 8' ' ' VAL . 18.2 mt -63.84 -45.09 91.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.55 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 52' ' ' LEU . 11.4 ptmt -71.67 -6.86 44.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.882 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -59.05 -42.4 90.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -84.36 -8.77 58.89 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.768 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.49 16.01 59.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.73 148.46 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.685 0.279 . . . . 0.0 110.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 120.16 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.173 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.06 132.84 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.75 128.44 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.495 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -96.19 136.17 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.426 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.83 -40.16 10.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.609 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.04 -177.0 19.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.8 mm? -88.57 135.14 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.524 ' OE1' ' OXT' ' A' ' 68' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' CG ' ' A' ' 1' ' ' MET . 1.8 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo -73.7 137.16 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.321 . . . . 0.0 112.104 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.96 147.85 42.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.446 ' ND1' HD23 ' A' ' 67' ' ' LEU . 1.8 t60 -114.36 126.28 54.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.678 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 7.3 mp0 -102.93 130.88 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.653 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.82 ' CE1' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -137.87 139.8 40.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.366 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.616 ' OG ' HD11 ' A' ' 65' ' ' LEU . 1.1 p -103.71 120.97 42.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.735 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 61' ' ' THR . 9.9 p -130.52 127.28 62.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.63 115.58 19.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mmt -67.2 116.0 7.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.056 0.455 . . . . 0.0 111.214 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.99 -40.88 4.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.22 31.48 5.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.297 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -17.87 -51.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.4 -51.91 48.27 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.82 -42.92 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.575 0.226 . . . . 0.0 110.903 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.15 -33.25 62.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.762 0.315 . . . . 0.0 110.657 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -64.44 -45.87 85.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.154 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.85 70.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.878 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.939 HG21 ' OG1' ' A' ' 58' ' ' THR . 58.1 t -66.08 -36.15 76.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.769 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -55.99 -35.6 66.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -56.54 -39.15 72.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.81 -18.75 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.299 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.79 ' N ' HG21 ' A' ' 54' ' ' THR . 53.3 tp -57.8 -33.15 68.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.224 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.569 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 8.9 m120 -53.75 -36.43 62.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.568 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -68.35 -45.17 73.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.394 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -79.61 -40.28 29.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.867 0.365 . . . . 0.0 110.959 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -100.58 -49.44 1.4 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.569 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 55.16 35.21 59.54 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 27' ' ' GLY . 23.1 m -127.73 -174.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.33 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.298 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -147.55 163.85 35.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.82 131.01 17.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.793 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.3 pp -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.55 99.88 8.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 1.3 mt -61.13 -41.08 79.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 27.6 Cg_exo -58.83 -30.78 93.77 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.604 2.203 . . . . 0.0 112.597 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -105.68 -7.09 18.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm 53.86 38.7 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.293 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.86 162.8 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.791 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 33' ' ' ILE . 16.9 t -133.52 122.66 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.221 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.01 113.85 26.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.19 136.37 61.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.325 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 3.0 tm-20 -108.79 115.91 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -128.86 163.77 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.78 -21.39 60.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 47' ' ' SER . 8.2 m-70 -109.08 -45.33 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.108 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 48' ' ' MET . 2.4 t 55.7 123.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.772 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 47' ' ' SER . 4.3 ttp 88.54 69.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.636 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.4 OUTLIER 163.5 -38.0 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.225 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -79.57 -41.59 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.577 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.785 HD23 HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -64.65 -53.87 40.71 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.56 -48.09 75.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.814 -178.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.14 76.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.79 HG21 ' N ' ' A' ' 23' ' ' LEU . 2.1 m -70.41 -45.95 64.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.252 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 51' ' ' LEU . 8.8 mp -60.14 -43.17 95.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.239 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' A' ' 59' ' ' GLY . 13.9 mmtp -66.49 -32.57 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -31.64 -44.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.035 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.939 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -84.38 -26.17 28.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.781 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 109.06 16.24 11.66 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.17 146.87 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.292 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.01 135.87 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.82 HG22 ' CE1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -117.9 132.69 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.945 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.516 ' C ' ' CE1' ' A' ' 6' ' ' PHE . 1.5 m -130.28 128.18 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 111.101 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 66' ' ' GLY . 9.2 t80 -86.07 118.83 25.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.193 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD11 ' OG ' ' A' ' 7' ' ' SER . 29.8 mt -100.29 -50.98 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.877 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 160.93 -179.54 36.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' O ' ' OXT' ' A' ' 68' ' ' GLU . 33.3 mt -101.13 136.69 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.567 ' OXT' ' O ' ' A' ' 67' ' ' LEU . 2.5 tm-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' OE2' ' A' ' 45' ' ' GLU . 32.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.1 Cg_endo -74.93 144.99 31.2 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.621 2.214 . . . . 0.0 112.028 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -95.8 143.75 26.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.664 ' CD2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -111.28 134.53 52.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -119.04 128.86 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.586 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -129.5 139.34 51.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.105 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -109.58 110.98 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.49 129.12 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.206 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 113.77 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 116.3 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.231 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -40.29 4.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.893 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -103.58 37.82 1.94 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -21.47 -48.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.86 -52.29 43.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -86.04 -44.77 12.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.576 0.227 . . . . 0.0 110.834 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -55.03 -34.18 63.3 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.825 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 tm-20 -71.95 -39.92 69.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -34.46 75.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.198 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.957 ' O ' HG22 ' A' ' 22' ' ' VAL . 33.4 t -59.48 -36.59 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.734 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 23' ' ' LEU . 37.5 t -56.56 -33.6 66.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.351 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -55.95 -42.13 75.73 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.653 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 19' ' ' VAL . 2.4 m -58.02 -18.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.49 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CB ' HG21 ' A' ' 54' ' ' THR . 6.3 tt -57.78 -32.37 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.296 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -52.76 -32.18 42.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.514 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -68.51 -45.19 72.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -41.11 23.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.054 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.96 -69.55 0.9 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.84 70.97 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -176.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.803 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -61.68 131.34 49.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.613 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -142.98 153.21 42.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.31 129.13 16.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.46 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -110.75 119.36 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.33 99.88 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.399 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.614 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 2.0 tp -61.34 -43.88 91.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 44.3 Cg_exo -52.63 -27.87 34.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.865 2.377 . . . . 0.0 112.769 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.86 -3.97 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mttt 52.66 38.08 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.172 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -137.85 169.52 17.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.601 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -136.13 120.72 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.074 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 t -108.22 113.77 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.09 137.8 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.086 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -107.7 115.33 29.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 164.74 22.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.596 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' OE2' ' SD ' ' A' ' 1' ' ' MET . 2.2 mm-40 -73.52 -35.84 65.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.714 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -115.08 -50.91 2.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.664 ' CB ' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 57.82 -179.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.393 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER 67.8 26.26 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.1 m-20 -158.1 -37.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.679 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -41.17 29.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.719 ' CD1' ' H ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -65.45 -52.12 55.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.262 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.817 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -66.24 -48.01 71.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.43 -47.4 79.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.313 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.636 HG21 ' CB ' ' A' ' 23' ' ' LEU . 22.2 p -69.51 -49.84 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.74 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 8' ' ' VAL . 5.3 mp -63.6 -44.14 94.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.487 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 -12.74 61.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.684 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.875 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -0.11 52.11 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.16 13.95 77.95 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.3 139.96 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 8' ' ' VAL . 85.6 m -61.27 131.47 50.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.408 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 62' ' ' VAL . 9.1 p -119.34 132.96 67.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.616 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -124.31 118.99 28.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 1.9 t80 -83.5 110.03 17.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.255 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.29 -44.81 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.732 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 64' ' ' TYR . . . 147.46 -170.74 28.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 4' ' ' HIS . 0.3 OUTLIER -129.2 141.54 51.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.257 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt0 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.594 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.9 ttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 1' ' ' MET . 20.7 Cg_exo -61.49 159.39 32.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.879 2.386 . . . . 0.0 112.068 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -127.46 143.97 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.439 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' HD23 ' A' ' 67' ' ' LEU . 2.9 t60 -117.98 140.22 50.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.466 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.46 129.95 56.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -125.54 139.22 53.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.074 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -107.75 116.02 31.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.888 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 124.88 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.65 120.06 22.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.5 mmt -66.71 116.88 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.006 0.432 . . . . 0.0 110.976 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' SG ' ' A' ' 12' ' ' CYS . 5.6 t -110.41 -33.5 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.029 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' A' ' 15' ' ' CYS . 73.8 m -105.72 36.11 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -15.7 -51.86 0.01 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -65.35 -54.56 25.99 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -86.12 -38.6 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.424 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.04 -33.08 56.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.622 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.01 -43.73 91.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.35 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.58 62.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 54' ' ' THR . 19.6 t -58.17 -36.05 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.43 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -32.48 62.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.422 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 33.0 mtm180 -55.69 -38.96 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.088 0.471 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 54' ' ' THR . 59.7 t -57.37 -19.65 11.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.686 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.82 -33.98 71.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.995 -178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 21' ' ' ARG . 1.8 m120 -60.11 -42.27 94.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -67.63 -44.57 77.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.324 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -79.42 -40.44 29.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.36 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.33 -58.03 1.1 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 12.82 69.76 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.16 -174.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -58.61 127.28 31.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.879 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -138.54 158.01 45.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.274 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.12 126.39 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.273 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 33' ' ' ILE . 11.2 tt -116.76 127.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.741 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.33 100.38 9.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.267 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -61.0 -51.38 79.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.421 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 38.6 Cg_exo -56.71 -27.54 71.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -7.15 19.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.06 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 52.66 38.88 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.958 0.408 . . . . 0.0 109.986 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -133.03 147.58 52.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 39' ' ' LYS . 6.4 t -123.76 120.96 61.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.132 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 115.09 29.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -123.97 136.3 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 112.077 -178.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 2.6 mp0 -109.03 115.55 30.29 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 p -144.85 164.86 29.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.396 0.617 . . . . 0.0 111.75 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -69.32 -33.99 73.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.695 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -111.5 -64.22 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.603 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.41 54.7 2.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptp -166.76 50.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.648 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' N ' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER 174.17 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.729 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.09 -37.79 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.863 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 42' ' ' ILE . 6.1 mt -65.02 -53.36 47.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.6 -51.59 66.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.83 84.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.804 HG21 ' HA ' ' A' ' 23' ' ' LEU . 16.5 p -69.19 -50.28 48.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.6 mp -63.99 -40.55 96.62 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.633 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -71.86 -17.3 62.14 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -50.79 -37.55 43.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.284 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.468 HG22 HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -87.09 7.74 26.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 110.442 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.6 13.35 82.04 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.31 148.75 37.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.659 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 61' ' ' THR . 5.4 t -75.15 128.14 34.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.392 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.48 134.01 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 t -137.69 125.63 22.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -81.29 124.78 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.442 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 7' ' ' SER . 77.9 mt -81.97 -50.25 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.35 174.82 20.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' ND1' ' A' ' 4' ' ' HIS . 5.9 mt -89.13 140.45 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.559 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.1 139.22 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.241 . . . . 0.0 112.157 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 141.3 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.367 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.44 ' C ' ' OE2' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -124.85 126.24 45.25 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.675 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 2.7 mp0 -109.07 129.16 55.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.643 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -125.1 140.37 52.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.336 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -108.75 110.18 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.533 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.848 HG11 HD22 ' A' ' 55' ' ' LEU . 6.0 p -131.31 135.86 58.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 1.1 m-20 -87.35 113.4 23.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.14 117.24 13.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.047 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.2 p -110.36 -24.17 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.372 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.8 m -105.79 26.57 9.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.959 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.19 -51.34 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.7 -54.71 26.95 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.69 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -85.81 -37.67 18.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.553 0.216 . . . . 0.0 110.846 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.4 -33.04 58.51 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -65.49 -45.35 83.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.416 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.72 68.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.982 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 54' ' ' THR . 5.3 t -65.34 -37.69 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.2 m -57.14 -35.86 70.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.382 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 71.0 mtt-85 -57.13 -40.92 78.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -61.45 -18.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 54' ' ' THR . 5.0 tt -58.32 -33.05 69.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.464 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 21' ' ' ARG . 9.8 p30 -53.56 -33.51 55.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.251 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.2 -45.48 73.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.059 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -40.13 24.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.373 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -99.48 -66.28 0.84 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.58 31.59 81.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' GLU . 34.7 m -125.96 -175.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.063 0.458 . . . . 0.0 110.91 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -68.51 123.9 22.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -149.27 156.24 41.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.63 147.6 43.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.347 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.39 118.02 56.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.105 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -115.41 99.09 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.36 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.796 ' N ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -62.55 -43.92 85.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.72 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 41.8 Cg_exo -52.55 -30.78 46.28 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.763 2.308 . . . . 0.0 113.13 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -105.92 -4.64 20.42 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.021 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mttt 52.72 38.75 27.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 40' ' ' VAL . 5.2 ttpt -134.18 152.83 52.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.18 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.28 121.41 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.915 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' ' HG3' ' A' ' 5' ' ' GLU . 7.7 t -104.56 114.61 28.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.883 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CG2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -124.81 136.39 60.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.736 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 12.9 tt0 -111.37 115.77 29.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.01 163.72 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 111.223 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 37.6 mt-10 -78.19 -16.38 57.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.512 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 46' ' ' HIS . 0.3 OUTLIER -107.33 -51.31 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' HIS . 18.3 p 59.04 133.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.787 ' H ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 77.04 50.2 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.5 t0 -171.77 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.227 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -39.3 33.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.787 HD11 ' H ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -64.96 -55.62 18.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.43 -52.41 65.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -48.04 77.7 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.281 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 23' ' ' LEU . 86.6 m -69.22 -49.05 59.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 111.319 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD22 HG11 ' A' ' 8' ' ' VAL . 92.9 mt -63.4 -36.07 82.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.4 mtpt -70.83 -29.32 65.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -42.7 -42.38 3.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.51 -179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -8.31 58.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.473 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 83.76 14.94 71.71 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 9' ' ' ASP . . . -77.34 143.7 38.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.39 126.92 29.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.76 136.05 49.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.473 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.3 t -137.74 120.36 16.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -77.46 129.52 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.31 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -82.99 -47.56 11.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.24 149.17 4.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 68' ' ' GLU . 1.3 tt -101.49 129.35 47.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.708 0.29 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.615 ' N ' HD23 ' A' ' 67' ' ' LEU . 3.1 tp10 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.07 147.8 88.55 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.824 2.35 . . . . 0.0 111.861 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -94.37 148.62 22.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.58 ' CE1' ' SD ' ' A' ' 48' ' ' MET . 17.4 t-160 -116.24 133.59 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -119.59 129.7 54.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.002 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -123.97 139.44 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.184 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -102.65 113.82 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.455 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 61' ' ' THR . 10.5 p -130.96 130.05 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.013 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -82.19 115.39 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.496 ' SD ' ' CA ' ' A' ' 13' ' ' GLY . 2.9 tmm? -66.77 116.22 7.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.967 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.4 m -110.8 -39.46 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.697 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -106.51 38.47 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.658 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -18.92 -51.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.33 -51.44 52.5 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -85.45 -44.72 12.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.241 . . . . 0.0 110.642 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -54.95 -33.0 61.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.333 . . . . 0.0 110.395 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -63.08 -45.38 92.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.229 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.42 -29.8 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG21 ' OG1' ' A' ' 58' ' ' THR . 3.0 t -65.69 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.564 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 t -56.54 -33.75 66.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.303 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -65.26 -40.32 93.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.814 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -58.59 -19.72 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.053 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 54' ' ' THR . 0.8 OUTLIER -59.41 -34.43 72.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.503 -179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.581 ' O ' ' CA ' ' A' ' 28' ' ' GLY . 1.4 t-20 -60.18 -31.64 70.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.365 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -67.69 -44.72 77.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.753 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -40.64 47.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 110.496 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.44 -57.36 0.89 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 24' ' ' ASN . . . 68.68 44.01 73.0 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.35 -175.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.09 0.471 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 129.59 23.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -137.68 152.84 49.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.783 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -146.55 124.75 12.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.69 118.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.949 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 100.26 7.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.349 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.1 -48.86 90.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 32.3 Cg_exo -54.51 -27.27 49.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.053 2.502 . . . . 0.0 112.764 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.94 -8.51 18.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.845 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.1 mttm 52.54 38.83 26.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.133 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -136.08 154.54 50.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.035 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 t -130.39 124.25 57.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -108.47 114.19 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.671 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -125.41 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.082 0.467 . . . . 0.0 111.693 -179.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.73 116.25 30.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.1 t -138.08 164.76 28.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 111.413 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.84 -27.75 60.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.58 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.11 -71.51 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.469 ' OG ' ' ND1' ' A' ' 4' ' ' HIS . 0.5 OUTLIER 61.43 153.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.336 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' CE1' ' A' ' 4' ' ' HIS . 2.0 tpp 71.75 37.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.433 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' CA ' HD21 ' A' ' 52' ' ' LEU . 23.5 t0 -170.4 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.15 -34.7 43.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.842 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 6' ' ' PHE . 2.9 mt -65.21 -53.63 41.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.499 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.849 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -55.24 -53.62 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 52' ' ' LEU . . . -63.37 -41.9 98.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 110.953 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 50' ' ' THR . 45.6 p -68.19 -48.83 64.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.778 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.48 -43.65 93.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.2 tptt -66.76 -19.89 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.751 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -37.58 -45.24 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.921 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.61 -24.3 29.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.495 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 106.42 15.85 16.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.96 148.1 38.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 0.0 110.665 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.5 m -61.94 132.74 53.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.374 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -113.23 133.1 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 t -137.37 119.19 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -78.16 112.65 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 65' ' ' LEU . 61.0 mt -76.8 -43.56 36.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.81 170.52 13.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -88.58 147.93 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.486 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.716 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.2 ttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 1' ' ' MET . 8.9 Cg_exo -67.5 136.41 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.623 2.215 . . . . 0.0 111.938 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -87.12 149.27 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.246 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.666 ' NE2' ' O ' ' A' ' 44' ' ' SER . 11.5 m-70 -117.16 134.47 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.966 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -112.93 129.62 56.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.745 ' CD1' HD12 ' A' ' 51' ' ' LEU . 1.6 m-85 -136.39 139.79 42.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.5 113.68 27.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.83 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.72 127.91 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.227 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.05 113.4 21.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 117.03 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.43 . . . . 0.0 111.141 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -109.55 -36.62 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' CYS . 1.3 m -93.6 27.02 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' O ' ' A' ' 12' ' ' CYS . . . -14.2 -50.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -64.78 -54.68 26.92 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.703 ' N ' ' O ' ' A' ' 12' ' ' CYS . 1.2 m -86.34 -37.71 18.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.568 0.223 . . . . 0.0 111.102 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' CYS . . . -54.46 -36.18 63.83 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.53 98.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 0.0 110.143 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.01 72.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.112 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.1 t -64.42 -37.65 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.54 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -34.18 68.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.828 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 83.2 mtt-85 -67.69 -52.63 35.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.347 . . . . 0.0 110.799 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -59.15 -19.8 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.875 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 23' ' ' LEU . 9.6 tt -59.33 -33.43 71.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.803 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.26 -29.24 31.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.0 110.137 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -66.14 -44.42 84.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.654 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 -37.71 67.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.561 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.35 -58.64 0.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 65.09 35.65 92.04 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -137.89 -172.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.0 110.543 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 4.5 ttpm? -56.23 132.06 49.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 5.4 p90 -148.65 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 133.13 16.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.338 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mm -118.74 110.64 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.67 99.57 8.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.952 0.406 . . . . 0.0 110.518 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -61.73 -44.37 90.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.288 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 45.8 Cg_exo -52.04 -30.49 40.47 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.85 2.367 . . . . 0.0 112.952 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -105.67 -2.84 22.89 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.169 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 52.66 38.95 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.111 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -135.52 156.81 48.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 33' ' ' ILE . 16.9 t -136.29 120.47 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.157 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.58 113.66 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -127.91 134.41 65.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -109.87 115.72 30.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -136.37 164.61 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.188 0.518 . . . . 0.0 111.399 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.88 -25.65 56.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 47' ' ' SER . 1.8 t-80 -74.65 -72.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.311 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.658 ' OG ' ' NE2' ' A' ' 4' ' ' HIS . 0.9 OUTLIER 75.14 104.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.822 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.618 ' C ' HD21 ' A' ' 52' ' ' LEU . 4.9 ttt 80.98 57.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.637 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 1.009 ' N ' HD21 ' A' ' 52' ' ' LEU . 10.9 t70 -174.94 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.053 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -79.72 -45.06 19.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -65.48 -54.39 29.05 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.009 HD21 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -54.6 -52.79 61.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.17 82.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.547 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 50' ' ' THR . 74.6 p -68.16 -50.19 56.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.694 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -63.22 -41.52 99.13 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.65 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' GLY . 20.7 mtpp -60.64 -23.82 65.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.3 mmtm -30.97 -52.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.436 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -85.06 -21.76 29.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.203 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 111.2 16.72 9.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.189 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.87 144.08 43.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.53 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.76 127.79 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.9 m -108.24 154.42 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 m -131.85 123.01 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -86.44 113.43 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.583 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -97.1 -51.02 4.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.7 -143.58 10.96 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.845 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.91 150.32 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.515 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.657 179.952 . . . . . . . . 0 0 . 1 stop_ save_